Calgary, Canada – TheNewswire - August 25, 2025 – DeepMarkit Corp. ("DeepMarkit" or the "Company") (TSXV: MKT) (OTC: MKTDF) (FRA: DEP) is pleased to provide a corporate update on its current subsidiaries and the opportunities under evaluation across key technology verticals.DeepMarkit Digital Corp.DeepMarkit Digital is focused on opportunities in the crypto ecosystem, including treasury management strategies, staking and validating activities, prediction markets, and related initiatives that support the de ...

Core Insights - BioSig Technologies, Inc. and Streamex Exchange Corporation have successfully completed a share exchange transaction, forming a combined company focused on the tokenization of real-world assets, particularly in the commodities sector [1][2][9] - The combined company aims to revolutionize commodity finance by bringing commodity markets on-chain through secure and scalable tokenization solutions [7][8] Leadership and Strategic Direction - The leadership team will include Henry McPhie as CEO, Morgan Lekstrom as Chairman, and Anthony Amato as a board member, guiding the company through its next growth phase [3][4][9] - Strategic advisors Frank Giustra and Mathew August will join to provide expertise in commodities and US capital markets, respectively [5][6] Market Position and Vision - The combined company is strategically positioned within the US$142.851 trillion global commodity market, aiming to unlock new value through tokenization [9] - Streamex believes that the future of finance lies in tokenization and decentralized markets, enhancing liquidity, accessibility, and efficiency for investors and institutions [8] Share Exchange Details - Existing Streamex shareholders will receive 75% of the fully diluted BioSig common stock in exchange for their shares, with an initial entitlement of 19.9% upon closing [14] - Following shareholder approval, current BioSig shareholders will hold 25% of the fully diluted BioSig common stock outstanding [14]

Core Viewpoint - BioSig Technologies, Inc. has signed a definitive share exchange agreement with Streamex Exchange Corporation, marking a significant milestone in the business combination aimed at enhancing the tokenization of real-world assets, particularly in the commodities sector [1][2]. Company Overview - BioSig Technologies is a medical technology company focused on innovative solutions, while Streamex specializes in the tokenization of real-world assets, particularly commodities [1][7]. - The combined entity will be led by Henry McPhie, Co-Founder and CEO of Streamex, with Anthony Amato transitioning to a board role [5]. Transaction Highlights - The share exchange will result in Streamex becoming a wholly owned subsidiary of BioSig, with existing Streamex shareholders entitled to receive 75% of the fully diluted BioSig common stock post-transaction [5][12]. - The transaction is expected to unlock new value in the US$142.85 trillion global commodity market by bringing commodities on-chain through secure tokenization solutions [5][13]. Strategic Additions - Notable strategic advisors have joined the combined company, including Frank Giustra, Mathew August, and Mitchell Williams, bringing extensive experience in commodities and capital markets [6]. Market Positioning - Streamex aims to revolutionize commodity finance by bridging traditional finance with the digital economy, enhancing liquidity, accessibility, and efficiency through innovative financial technologies and blockchain [8].